NCT00075413撤回2 期
A Pilot Phase II Protocol Of Arsenic Trioxide (TRISENOX) In Subjects With Advanced Carcinoma Of The Breast
适应症
相关药物
试验速览
研究概览
简要总结
RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well arsenic trioxide works in treating women with locally advanced or metastatic breast cancer.
详细描述
OBJECTIVES:
Primary
- Determine the safety and activity of arsenic trioxide in women with locally advanced or metastatic breast cancer.
- Determine the qualitative and quantitative toxic effects of this drug in these patients.
Secondary
- Determine the response, in terms of objective tumor response and response duration, in patients treated with this drug.
- Determine the patterns of failure and survival in patients treated with this drug.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 120 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerLung CancerNCT00075426The University of Texas Medical Branch, Galveston30
已完成
1 期
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed GliomasBrain and Central Nervous System TumorsNCT00095771Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins36
终止
2 期
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic SyndromesMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsLeukemiaNCT00104806Wake Forest University Health Sciences5
已完成
1 期
Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmNCT00006021University of Miami22
已完成
2 期
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaLeukemiaNCT00006008Eastern Cooperative Oncology Group